Search for: "Watson Laboratories Inc." Results 61 - 80 of 131
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jul 2016, 2:54 am
In Thermo LabSystems [TTABlogged here], the TTAB found WATSON to be primarily a surname for laboratory management software. [read post]
12 Oct 2010, 8:56 pm by Kelly
(FDA Law Blog) Lyrica (Pregabalin) – US: Pfizer files patent infringement suit against Lupin in response to Para IV certification filing (Patent Docs) Opana (Oxymorphone) – US: Watson reaches settlement with Endo over Opana ER (SmartBrief) OsmoPrep (Sodium biphosphate, Sodium phosphate) – US: Salix Pharma and Novel Labs settle OsmoPrep patent litigation (Patent Docs) Sanctura XR (Trospium) – US: Allergan file patent infringement complaints against Paddock… [read post]
24 Mar 2009, 12:02 am
The recalled tablets were manufactured by Watson Laboratories, Inc. [read post]
19 Jan 2011, 2:44 pm by Phil
The case goes back to $398 million that Bayer allegedly paid Watson Pharmaceuticals Inc., Barr Laboratories Inc. and others supposedly in exchange for the companies not marketing lower-cost generic versions of the antibiotic Cipro. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
8 Jun 2010, 8:14 am by Brian Wm. Higgins
Watson Laboratories, Inc., No. 1:2010cv01323 (filed May 24, 2010); this Hatch-Waxman patent infringement lawsuit was brought by Genzyme after Watson sought Food and Drug Administration (FDA) approval to market in the US a generic version of the company's Renvela(R) drug product (sevelamer carbonate). [read post]
18 Jul 2011, 5:16 pm by FDABlog HPM
(“Cephalon”) on March 15, 2011 challenging FDA’s January 7, 2011 approval of Watson Laboratories, Inc. [read post]
1 Dec 2011, 2:02 pm by Tom Lamb
(NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura(TM) (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz(R) oral contraceptive product. [read post]
9 Nov 2007, 4:44 am
See, e.g., the Board's 2004 decision in favor of registrability of MOSCONI for billiard equipment (TTABlogged here), and this year's refusal of WATSON for laboratory software (here).Text Copyright John L. [read post]
26 Feb 2014, 5:37 pm
  Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
24 Jan 2010, 6:43 am by by PritzkerLaw
 Brands involved in the recall include Daniele, Dietz & Watson, Boar's Head and Black Bear of the Black Forest. [read post]